International Patent: SINGLE-COMPONENT SPLEEN-TARGETED LIPID NANOPARTICLE AND USE THEREOF

GENEVA, July 31 -- GREATER BAY AREA INSTITUTE OF PRECISION MEDICINE (GUANGZHOU) filed a patent application (CN2025/080603) for “SINGLE-COMPONENT SPLEEN-TARGETED LIPID NANOPARTICLE AND USE THEREOF”. With publication no. WO/2026/156977, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....